Navigation Links
Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
Date:11/5/2012

PRINCETON, N.J., Nov. 5, 2012 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today reported results for its third quarter ended September 30, 2012.  On a GAAP basis, net revenue was $545 million.  Excluding revenue from facilities in wind-down, pro forma net revenue was $542 million.  On a GAAP basis, the company reported earnings of $0.69 per diluted share in the third quarter.  Excluding losses from facilities in wind-down, restructuring costs and other charges and favorable income tax developments during the quarter, the company reported earnings per diluted share of $0.72.

"Third quarter pro forma earnings were better than expected, increasing $0.07 sequentially, due to significantly improved profitability in toxicology coupled with continued strong performances in clinical development and central laboratories. Our performance this quarter demonstrates the leverage in our scalable business model when commercial success is combined with our lower cost infrastructure," said Joe Herring, Chairman and Chief Executive Officer.  "On the sales front, clinical development and central laboratories continued to deliver strong new orders, driving adjusted net orders of $701 million and an adjusted book-to-bill of 1.29 to 1.  We continue to have significant pending proposals. In addition, our strategic information technology projects continue to progress on-time and on-budget.

"Late-Stage Development revenues grew 6.9% year-on-year, or 13.1% on a constant currency basis. Revenue growth was led by 18% growth in clinical development and continued year-on-year and sequential growth in central laboratories, which more than offset a decline in our market access services. Pro forma operating margins increased 70 basis points year-on-year to 20.0%, but declined as expected from the second quarter level on increased spending on strategic IT projects, conti
'/>"/>

SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
2. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
3. Covance to Present at the Morgan Stanley Global Healthcare Conference
4. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
5. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
6. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
7. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
8. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
9. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
10. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
11. Luminex Corporation Reports First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... -- The fairness of the proposed acquisition of Thoratec Corporation ... Jude") is the subject of an investigation by WeissLaw ...  The investigation is focusing on possible breaches of fiduciary ... of Directors of THOR for agreeing to sell the ... announced it had reached a definitive agreement for St. ...
(Date:7/27/2015)... , July 20, 2015 ... has announced the addition of the "Cardiometabolic ... Afrezza,s discounted pricing is in line ... is critical to the product,s commercial appeal. However, ... prevent Afrezza from gaining a sizeable share of ...
(Date:7/27/2015)...  Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is ... the securities of AMAG Pharmaceuticals Inc. ("AMAG" or ... advised to contact Peretz Bronstein or ... at info@bgandg.com or 212-697-6484. ... its officers and/or directors have violated Sections 10(b) ...
Breaking Medicine Technology:WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 3SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals Inc. 2
... PRINCETON, N.J. , June 21 Celator Pharmaceuticals today ... (Nasdaq: CEPH). The research agreement provides for the utilization of Celator,s ... at Cephalon. , , ... "We are pleased that work with this research program has ...
... June 21 U.S. District Court Judge Sidney A. Fitzwater ... class action lawsuit that left hundreds of premature babies with life threatening medical ... Canada will receive compensation under the settlement. , ... "It took years of litigation and research to pry relevant information ...
Cached Medicine Technology:Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc. 2Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc. 3Fort Worth Attorney Dwain Dent Comments on Final Judgment in Case That Left Hundreds of Babies Dead or Injured 2
(Date:7/27/2015)... ... July 27, 2015 , ... According to an article published by the ... has increased in Tennessee stemming from intravenous drug use. Intravenous drug use causes more ... for contracting communicable diseases including Hepatitis B and C and HIV. Drug treatment facilities ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... , providing a new way to understand and share your geospatial experience. These ... creatively designed maps to solve distinct business problems. , “Our world is more ...
(Date:7/27/2015)... ... July 27, 2015 , ... Dentist in Los Angeles , Dr. Poneh Ghasri, is ... of new beginnings for many people. Teeth whitening can help brighten up a person’s look, ... whitening is the safest and most effective way to get a whiter smile. Dr. Ghasri, ...
(Date:7/27/2015)... ... 2015 , ... Sher Fertility Institute, a national network of fertility ... physician to their clinical team in Las Vegas. , Dr. Mark Severino ... successful Reproductive Endocrinology teams in the region. , Combined Drs. Sher and Severino have ...
(Date:7/27/2015)... ... July 27, 2015 , ... The Advocator Group, LLC, a ... Jon Cogswell as the vice president of client services. Mr. Cogswell has over ... significant role in the growth and transformation of several businesses, including Bob’s Discount ...
Breaking Medicine News(10 mins):Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 2Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 3Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 2Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 3Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Is Now Offering a Teeth Whitening Special Just in Time for Summer 2Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 2Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 3Health News:The Advocator Group, LLC Announces Jonathan Cogswell as Vice President of Client Services 2Health News:The Advocator Group, LLC Announces Jonathan Cogswell as Vice President of Client Services 3
... come up with a novel idea to boost up the sales of ... has announced a handsome reward of Rs. 100,000 for those who prove ... case has been registered in the state. And despite this, the bird ... Rs.100,000 if anyone proves bird flu case in the state," Rajesh Kumar ...
... the steel town were affected by a mysterious viral fever. ... a slum// cluster in Panposh on the outskirts of Rourkela, famous ... to other parts of the town. ,The high fever ... senior district health official. ,Most of the patients have ...
... days and devouring every bit of the Flu news, ... Own Country// , as recent as yesterday, has demonstrated a ... Flu or no flu. The Kerala Chicken Merchants’ Association threw ... hotel in Malappuram, Kerala. The party was open for all, ...
... Health officials have now urged cat owners to keep pets indoors. ... Ruegen. Initially it is in this region that more than 100 ... head of Germany's Friedrich Loeffler Institute said that the cat could ... disease was also detected among the wild cats in Asia. But ...
... After the cooling down of the bird flu scare, the ... diet of the non-veggies and has decided to bring back ... withdrawn the order prohibiting the serving of chickens and eggs ... catering units," the Railway ministry said in a statement. "It ...
... goods including small cars, anti-AIDS drugs, anti-cancer drugs would ... is one of the highlights of the annual budget ... ,The beneficiaries of this reduction will be the 800, ... the Tata Indica. The prices of 10 anti-AIDS drugs ...
Cached Medicine News:Health News:Bird Flu attacks the feline community 2
The Shandon Cryotome E Cryostat model features an automated, precise electronic specimen advance system....
The Shandon Pathcentre is a high-volume, totally enclosed tissue processor that allows complete user control and excellent continuous reagent agitation....
... Shandon Excelsior Tissue Processor is ... using traditional reagents today. It ... outstanding features to provide benefits ... increased productivity, reagent cost savings ...
The Shandon Grosslab Grossing Workstation comes in a bench top or stand alone design for the gross examination and sectioning of specimens....
Medicine Products: